E4M: 1-{4-[(6S,6aR,7R)-3-amino-6,7-dimethyl-1-oxo-1,2,5,6,6a,7-hexahydro-8H-imidazo[1,5-f]pteridin-10-ium-8-yl]phenyl}-1-deoxy-5-O-{5-O-[(S)-{[(1S)-1,3-dicarboxypropyl]oxy}(hydroxy)phosphoryl]-alpha-D-ribofuranosyl}-D-ribitol
E4M is a Ligand Of Interest in 3IQF designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
| 3IQF_E4M_H_284 | 95% | 13% | 0.043 | 0.983 | 2.09 | 1.77 | 4 | 11 | 4 | 0 | 83% | 1 |
| 3IQF_E4M_I_284 | 94% | 13% | 0.045 | 0.979 | 2.02 | 1.83 | 4 | 11 | 4 | 0 | 83% | 1 |
| 3IQF_E4M_L_284 | 93% | 13% | 0.048 | 0.978 | 2.17 | 1.73 | 2 | 11 | 0 | 0 | 83% | 1 |
| 3IQF_E4M_D_284 | 93% | 13% | 0.051 | 0.981 | 2.05 | 1.85 | 3 | 11 | 0 | 0 | 83% | 1 |
| 3IQF_E4M_E_284 | 92% | 14% | 0.049 | 0.977 | 2.11 | 1.69 | 5 | 10 | 0 | 0 | 83% | 1 |
| 3IQF_E4M_K_284 | 91% | 15% | 0.053 | 0.974 | 2.12 | 1.54 | 4 | 7 | 2 | 0 | 83% | 1 |
| 3IQF_E4M_F_284 | 91% | 14% | 0.053 | 0.974 | 2.01 | 1.72 | 5 | 9 | 1 | 0 | 83% | 1 |
| 3IQF_E4M_G_284 | 88% | 12% | 0.061 | 0.973 | 1.94 | 1.98 | 5 | 11 | 2 | 0 | 83% | 0.9 |
| 3IQF_E4M_B_284 | 88% | 12% | 0.057 | 0.968 | 2.15 | 1.78 | 7 | 9 | 2 | 0 | 83% | 1 |
| 3IQF_E4M_C_284 | 88% | 13% | 0.06 | 0.97 | 2.19 | 1.66 | 2 | 11 | 3 | 0 | 83% | 1 |
| 3IQF_E4M_J_284 | 87% | 15% | 0.063 | 0.969 | 2.03 | 1.66 | 2 | 9 | 3 | 0 | 83% | 1 |
| 3IQF_E4M_A_284 | 85% | 18% | 0.068 | 0.967 | 1.89 | 1.55 | 2 | 10 | 0 | 0 | 83% | 0.9 |
| 6HAE_E4M_A_402 | 85% | 32% | 0.086 | 0.956 | 1.22 | 1.37 | 3 | 7 | 0 | 0 | 100% | 1 |
| 6HAV_E4M_A_412 | 83% | 25% | 0.097 | 0.962 | 1.64 | 1.31 | 3 | 10 | 14 | 0 | 100% | 1 |
| 6HUX_E4M_A_412 | 70% | 22% | 0.068 | 0.966 | 1.48 | 1.65 | 3 | 6 | 0 | 0 | 56% | 1 |